Skip to main content
Fig. 5 | Stem Cell Research & Therapy

Fig. 5

From: Induced pluripotent stem cell-derived endothelial progenitor cells attenuate ischemic acute kidney injury and cardiac dysfunction

Fig. 5

a–i Systemic human iPS cell-derived iEPC therapy increased the plasma concentrations of angiogenesis-related proteins. Bar charts denoting the relative folds of plasma angiogenesis-related proteins—including Angpt1, Angpt2, VEGF-C, MMP 9, FGF 1, FGF 2, IGFBP-1, IGFBP-2, and TGF-β1—on day 2 after acute kidney injury (AKI). N = 3 per group. Data are expressed as mean ± SEM. *P < 0.001 AKI-iEPC vs. AKI-V group

Back to article page